Breaking News Instant updates and real-time market news.

TFFP

TFF Pharmaceuticals

$13.68 /

+0.02 (+0.15%)

09:08
03/09/21
03/09
09:08
03/09/21
09:08

TFF Pharmaceuticals and NeuroRX in feasibility collaboration

NeuroRx and TFF Pharmaceuticals are announcing that the companies have entered into a feasibility and material transfer agreement. Under the Feasibility Agreement, NeuroRx is delivering ZYESAMI materials to TFF in order to perform feasibility formulation work and testing. The goal of this feasibility work is to formulate and identify an optimal, long-term stable formulation of ZYESAMI into a dry powder form, which has superior aerosol properties for delivery directly to the lungs. ZYESAMI is a synthetic form of a naturally occurring peptide found in the lung called Vasoactive Intestinal Peptide, which is known to protect the Alveolar Type II cell that is targeted by the SARS-CoV-2 virus. The symptoms of COVID-19 are attributable to decreased surfactant production and increased cytokine production caused by Coronavirus infection of the Type II cell. This may also be a common pathway in sepsis-induced Acute Respiratory Distress Syndrome and Checkpoint Inhibitor induced pneumonitis associated with certain cancer drugs. Loss of surfactant production in the lung may be the direct cause of the profound hypoxia or respiratory failure seen in COVID-19. The ability to deliver VIP directly to the lung via inhalation could have important therapeutic implications and potentially broaden the application of the drug to patients less severely affected with COVID-19. "We are excited that ZYESAMI has demonstrated a highly significant reduction in time to hospital discharge for seriously ill COVID-19 patients treated with High Flow Nasal Oxygen, along with an increased likelihood of recovery and excellent safety," said Jonathan C. Javitt, M.D., M.P.H., CEO of NeuroRx. "Although our current production methods yield a drug that is sufficiently stable for emergency use, a long-term, shelf-stable formulation will be needed for ongoing use of ZYESAMI, once the pandemic subsides. The thin-film freezing technology holds great promise in potentially making this available to patients with other stages of COVID-19 with an inhaled form of ZYESAMI."

  • 10

    Mar

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Innoviva to acquire Entasis Therapeutics for $2.20 per share in cash » 08:32
05/23/22
05/23
08:32
05/23/22
08:32
INVA

Innoviva

$16.28 /

+0.37 (+2.33%)

, ETTX

Entasis Therapeutics

$1.82 /

-0.015 (-0.82%)

Innoviva and Entasis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INVA Innoviva
$16.28 /

+0.37 (+2.33%)

ETTX Entasis Therapeutics
$1.82 /

-0.015 (-0.82%)

INVA Innoviva
$16.28 /

+0.37 (+2.33%)

05/06/22 Cantor Fitzgerald
Entasis Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
03/08/22 Wedbush
Entasis Therapeutics downgraded to Neutral from Outperform at Wedbush
03/04/22 H.C. Wainwright
Entasis Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
02/11/22 EF Hutton
Innoviva initiated with a Buy at EF Hutton
ETTX Entasis Therapeutics
$1.82 /

-0.015 (-0.82%)

05/06/22 Cantor Fitzgerald
Entasis Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
05/06/22 Cantor Fitzgerald
Entasis downgraded to Neutral from Overweight at Cantor Fitzgerald
03/16/22 Alliance Global Partners
Entasis Therapeutics downgraded to Neutral from Buy at Alliance Global Partners
03/08/22 Wedbush
Entasis Therapeutics downgraded to Neutral from Outperform at Wedbush
ETTX Entasis Therapeutics
$1.82 /

-0.015 (-0.82%)

ETTX Entasis Therapeutics
$1.82 /

-0.015 (-0.82%)

Hot Stocks
JPMorgan: 2023 expense outlook 'may be a bit higher' than $79.5B » 08:32
05/23/22
05/23
08:32
05/23/22
08:32
JPM

JPMorgan

$117.34 /

-0.945 (-0.80%)

JPMorgan says the 2023…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

05/13/22 Jefferies
JPMorgan price target lowered to $125 from $141 at Jefferies
05/03/22 Oppenheimer
Oppenheimer upgrades JPMorgan to Outperform on recent share weakness
05/03/22 Oppenheimer
JPMorgan upgraded to Outperform from Perform at Oppenheimer
04/14/22 Argus
JPMorgan price target lowered to $155 from $177 at Argus
JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

Hot Stocks
Catalyst Biosciences sells complement portfolio for $60M » 08:32
05/23/22
05/23
08:32
05/23/22
08:32
CBIO

Catalyst Biosciences

/

+

, VRTX

Vertex Pharmaceuticals

$258.71 /

+3.265 (+1.28%)

Catalyst Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBIO Catalyst Biosciences
/

+

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

CBIO Catalyst Biosciences
/

+

03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
11/12/21 Raymond James
Catalyst Biosciences downgraded to Market Perform from Outperform at Raymond James
VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

06:45 Today SVB Leerink
Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink
05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird
CBIO Catalyst Biosciences
/

+

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

CBIO Catalyst Biosciences
/

+

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

Recommendations
ShockWave Medical's China approval adds growth driver, says Piper Sandler » 08:31
05/23/22
05/23
08:31
05/23/22
08:31
SWAV

ShockWave Medical

$158.27 /

-1.78 (-1.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$158.27 /

-1.78 (-1.11%)

SWAV ShockWave Medical
$158.27 /

-1.78 (-1.11%)

05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
05/10/22 Wells Fargo
ShockWave Medical price target lowered to $176 from $235 at Wells Fargo
05/10/22 Piper Sandler
ShockWave pullback an opportunity after 'strong' Q1, says Piper Sandler
04/05/22 Wolfe Research
ShockWave Medical initiated with an Outperform at Wolfe Research
SWAV ShockWave Medical
$158.27 /

-1.78 (-1.11%)

SWAV ShockWave Medical
$158.27 /

-1.78 (-1.11%)

SWAV ShockWave Medical
$158.27 /

-1.78 (-1.11%)

Recommendations
Salesforce price target lowered to $260 from $330 at Jefferies » 08:31
05/23/22
05/23
08:31
05/23/22
08:31
CRM

Salesforce

$159.67 /

+4.26 (+2.74%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$159.67 /

+4.26 (+2.74%)

CRM Salesforce
$159.67 /

+4.26 (+2.74%)

07:40 Today Cowen
Salesforce price target lowered to $225 from $285 at Cowen
05/20/22 JPMorgan
Salesforce shares 'too cheap to ignore,' says JPMorgan
05/20/22 Barclays
Salesforce price target lowered to $208 from $275 at Barclays
05/18/22 Roth Capital
Roth Capital upgrades Salesforce to Buy with $242 price target
CRM Salesforce
$159.67 /

+4.26 (+2.74%)

CRM Salesforce
$159.67 /

+4.26 (+2.74%)

CRM Salesforce
$159.67 /

+4.26 (+2.74%)

CRM Salesforce
$159.67 /

+4.26 (+2.74%)

Recommendations
Medtronic price target lowered to $125 from $141 at Cowen » 08:31
05/23/22
05/23
08:31
05/23/22
08:31
MDT

Medtronic

$102.59 /

-0.17 (-0.17%)

Cowen analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$102.59 /

-0.17 (-0.17%)

MDT Medtronic
$102.59 /

-0.17 (-0.17%)

05/17/22 Citi
Medtronic price target lowered to $120 from $127 at Citi
04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
04/12/22 Truist
Truist starts six stocks in Medical Supplies and Devices, assumes eight others
04/12/22 Truist
Medtronic assumed at Hold from Buy at Truist
MDT Medtronic
$102.59 /

-0.17 (-0.17%)

MDT Medtronic
$102.59 /

-0.17 (-0.17%)

MDT Medtronic
$102.59 /

-0.17 (-0.17%)

MDT Medtronic
$102.59 /

-0.17 (-0.17%)

Recommendations
MicroStrategy price target lowered to $215 from $225 at Jefferies » 08:30
05/23/22
05/23
08:30
05/23/22
08:30
MSTR

MicroStrategy

$202.61 /

-7.71 (-3.67%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

05/16/22 Jefferies
MicroStrategy does not face liquidity, solvency risk, says Jefferies
05/13/22 William Blair
MicroStrategy can 'comfortably' support interest payments, says William Blair
05/04/22 Canaccord
MicroStrategy price target lowered to $453 from $540 at Canaccord
02/02/22 Canaccord
MicroStrategy price target lowered to $540 from $871 at Canaccord
MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

MSTR MicroStrategy
$202.61 /

-7.71 (-3.67%)

Recommendations
Dropbox price target lowered to $30 from $35 at Jefferies » 08:30
05/23/22
05/23
08:30
05/23/22
08:30
DBX

Dropbox

$20.18 /

-0.17 (-0.84%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBX Dropbox
$20.18 /

-0.17 (-0.84%)

DBX Dropbox
$20.18 /

-0.17 (-0.84%)

02/18/22 JMP Securities
Dropbox price target lowered to $30 from $39 at JMP Securities
12/02/21 Berenberg
Dropbox initiated with a Hold at Berenberg
08/06/21 Jefferies
Dropbox price target raised to $40 from $38 at Jefferies
06/10/21 RBC Capital
Dropbox assumed with an Outperform at RBC Capital
DBX Dropbox
$20.18 /

-0.17 (-0.84%)

DBX Dropbox
$20.18 /

-0.17 (-0.84%)

DBX Dropbox
$20.18 /

-0.17 (-0.84%)

Options
One new option listing on May 23rd » 08:30
05/23/22
05/23
08:30
05/23/22
08:30
LLAP

Terran Orbital

$5.14 /

+0.36 (+7.53%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLAP Terran Orbital
$5.14 /

+0.36 (+7.53%)

LLAP Terran Orbital
$5.14 /

+0.36 (+7.53%)

05/16/22 Canaccord
Terran Orbital price target lowered to $18 from $22 at Canaccord
04/20/22 Jefferies
Terran Orbital initiated with a Buy at Jefferies
04/08/22 Canaccord
Canaccord starts 'premier' small satellite maker Terran Orbital at Buy
04/08/22 Canaccord
Terran Orbital initiated with a Buy at Canaccord
LLAP Terran Orbital
$5.14 /

+0.36 (+7.53%)

Recommendations
Upland Software price target lowered to $14 from $17 at Jefferies » 08:30
05/23/22
05/23
08:30
05/23/22
08:30
UPLD

Upland Software

$13.47 /

+0.05 (+0.37%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPLD Upland Software
$13.47 /

+0.05 (+0.37%)

UPLD Upland Software
$13.47 /

+0.05 (+0.37%)

05/05/22 Needham
Upland Software price target lowered to $25 from $40 at Needham
02/25/22 Roth Capital
Upland Software price target lowered to $30 from $58 at Roth Capital
02/25/22 Canaccord
Upland Software price target lowered to $24 from $30 at Canaccord
01/11/22 Truist
Upland Software price target lowered to $30 from $44 at Truist
UPLD Upland Software
$13.47 /

+0.05 (+0.37%)

Hot Stocks
JPMorgan sees upside to Q4 $66B NII view 'in benign environment'  08:29
05/23/22
05/23
08:29
05/23/22
08:29
JPM

JPMorgan

$117.34 /

-0.945 (-0.80%)

 
ShowHide Related Items >><<
JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

05/13/22 Jefferies
JPMorgan price target lowered to $125 from $141 at Jefferies
05/03/22 Oppenheimer
Oppenheimer upgrades JPMorgan to Outperform on recent share weakness
05/03/22 Oppenheimer
JPMorgan upgraded to Outperform from Perform at Oppenheimer
04/14/22 Argus
JPMorgan price target lowered to $155 from $177 at Argus
JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

JPM JPMorgan
$117.34 /

-0.945 (-0.80%)

Recommendations
Freshworks price target lowered to $17 from $18 at Jefferies » 08:28
05/23/22
05/23
08:28
05/23/22
08:28
FRSH

Freshworks

$15.89 /

+0.12 (+0.76%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRSH Freshworks
$15.89 /

+0.12 (+0.76%)

FRSH Freshworks
$15.89 /

+0.12 (+0.76%)

05/04/22 JMP Securities
Freshworks price target lowered to $29 from $41 at JMP Securities
05/04/22 Canaccord
Freshworks price target lowered to $21 from $25 at Canaccord
05/04/22 Needham
Freshworks price target lowered to $25 from $40 at Needham
05/04/22 Oppenheimer
Freshworks price target lowered to $26 from $36 at Oppenheimer
FRSH Freshworks
$15.89 /

+0.12 (+0.76%)

  • 22
    Sep
FRSH Freshworks
$15.89 /

+0.12 (+0.76%)

FRSH Freshworks
$15.89 /

+0.12 (+0.76%)

Recommendations
CS Disco price target lowered to $35 from $40 at Jefferies » 08:27
05/23/22
05/23
08:27
05/23/22
08:27
LAW

CS Disco

$24.02 /

+1.82 (+8.20%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAW CS Disco
$24.02 /

+1.82 (+8.20%)

LAW CS Disco
$24.02 /

+1.82 (+8.20%)

05/13/22 Needham
CS Disco price target lowered to $35 from $50 at Needham
05/13/22 Cowen
CS Disco price target lowered to $35 from $45 at Cowen
05/13/22 Canaccord
CS Disco price target lowered to $35 from $45 at Canaccord
03/21/22 Stifel
CS Disco price target lowered to $50 from $60 at Stifel
LAW CS Disco
$24.02 /

+1.82 (+8.20%)

  • 15
    Sep
  • 21
    Jul
LAW CS Disco
$24.02 /

+1.82 (+8.20%)

Recommendations
Procore price target lowered to $75 from $90 at Jefferies » 08:27
05/23/22
05/23
08:27
05/23/22
08:27
PCOR

Procore

$43.44 /

-0.655 (-1.49%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$43.44 /

-0.655 (-1.49%)

PCOR Procore
$43.44 /

-0.655 (-1.49%)

05/05/22 Oppenheimer
Procore price target lowered to $70 from $85 at Oppenheimer
05/05/22 Barclays
Procore price target lowered to $70 from $76 at Barclays
05/05/22 Mizuho
Procore price target lowered to $70 from $75 at Mizuho
04/12/22 Barclays
Procore price target lowered to $76 from $90 at Barclays
PCOR Procore
$43.44 /

-0.655 (-1.49%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:26
05/23/22
05/23
08:26
05/23/22
08:26
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

Recommendations
Asana price target lowered to $23 from $40 at Jefferies » 08:26
05/23/22
05/23
08:26
05/23/22
08:26
ASAN

Asana

$21.44 /

-1.265 (-5.57%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$21.44 /

-1.265 (-5.57%)

ASAN Asana
$21.44 /

-1.265 (-5.57%)

03/10/22 JMP Securities
Asana price target lowered to $63 from $95 at JMP Securities
03/10/22 RBC Capital
Asana price target lowered to $38 from $60 at RBC Capital
03/10/22 Baird
Asana price target lowered to $65 from $110 at Baird
03/10/22 KeyBanc
Asana price target lowered to $61 from $97 at KeyBanc
ASAN Asana
$21.44 /

-1.265 (-5.57%)

ASAN Asana
$21.44 /

-1.265 (-5.57%)

ASAN Asana
$21.44 /

-1.265 (-5.57%)

Recommendations
Smartsheet price target lowered to $50 from $75 at Jefferies » 08:25
05/23/22
05/23
08:25
05/23/22
08:25
SMAR

Smartsheet

$36.31 /

-0.38 (-1.04%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMAR Smartsheet
$36.31 /

-0.38 (-1.04%)

SMAR Smartsheet
$36.31 /

-0.38 (-1.04%)

05/18/22 Wells Fargo
Smartsheet price target lowered to $55 from $70 at Wells Fargo
03/17/22 BMO Capital
Smartsheet price target lowered to $50 from $55 at BMO Capital
03/16/22 Needham
Smartsheet price target lowered to $57 from $100 at Needham
03/16/22 Canaccord
Smartsheet price target lowered to $60 from $80 at Canaccord
SMAR Smartsheet
$36.31 /

-0.38 (-1.04%)

SMAR Smartsheet
$36.31 /

-0.38 (-1.04%)

SMAR Smartsheet
$36.31 /

-0.38 (-1.04%)

Recommendations
Cloudflare price target lowered to $55 from $75 at Jefferies » 08:25
05/23/22
05/23
08:25
05/23/22
08:25
NET

Cloudflare

$55.69 /

-2.32 (-4.00%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$55.69 /

-2.32 (-4.00%)

NET Cloudflare
$55.69 /

-2.32 (-4.00%)

05/16/22 Needham
Cloudflare price target lowered to $100 from $245 at Needham
05/10/22 Truist
Cloudflare price target lowered to $100 from $140 at Truist
05/06/22 Truist
Cloudflare price target lowered to $140 from $180 at Truist
05/06/22 Mizuho
Cloudflare price target lowered to $90 from $135 at Mizuho
NET Cloudflare
$55.69 /

-2.32 (-4.00%)

NET Cloudflare
$55.69 /

-2.32 (-4.00%)

NET Cloudflare
$55.69 /

-2.32 (-4.00%)

NET Cloudflare
$55.69 /

-2.32 (-4.00%)

Hot Stocks
Nymox trading halted, news pending  08:25
05/23/22
05/23
08:25
05/23/22
08:25
NYMX

Nymox

$1.25 /

+ (+0.00%)

 
ShowHide Related Items >><<
NYMX Nymox
$1.25 /

+ (+0.00%)

Recommendations
Sumo Logic price target lowered to $8.50 from $12 at Jefferies » 08:25
05/23/22
05/23
08:25
05/23/22
08:25
SUMO

Sumo Logic

$7.70 /

+0.015 (+0.20%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SUMO Sumo Logic
$7.70 /

+0.015 (+0.20%)

SUMO Sumo Logic
$7.70 /

+0.015 (+0.20%)

07:42 Today RBC Capital
Sumo Logic price target lowered to $14 from $17 at RBC Capital
03/09/22 Piper Sandler
Sumo Logic price target lowered to $12.50 from $15 at Piper Sandler
01/06/22 Jefferies
Sumo Logic price target lowered to $14 from $16 at Jefferies
01/06/22 Piper Sandler
Sumo Logic price target lowered to $15 from $16 at Piper Sandler
SUMO Sumo Logic
$7.70 /

+0.015 (+0.20%)

SUMO Sumo Logic
$7.70 /

+0.015 (+0.20%)

SUMO Sumo Logic
$7.70 /

+0.015 (+0.20%)

Recommendations
Elastic price target lowered to $60 from $90 at Jefferies » 08:24
05/23/22
05/23
08:24
05/23/22
08:24
ESTC

Elastic

$60.10 /

+0.19 (+0.32%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$60.10 /

+0.19 (+0.32%)

ESTC Elastic
$60.10 /

+0.19 (+0.32%)

05/20/22 Barclays
Elastic price target lowered to $80 from $135 at Barclays
05/10/22 Truist
Elastic price target lowered to $110 from $135 at Truist
04/25/22 William Blair
Elastic initiated with an Outperform at William Blair
04/06/22 Citi
Elastic should be bought on pullbacks, says Citi
ESTC Elastic
$60.10 /

+0.19 (+0.32%)

ESTC Elastic
$60.10 /

+0.19 (+0.32%)

ESTC Elastic
$60.10 /

+0.19 (+0.32%)

Recommendations
Datadog price target lowered to $125 from $170 at Jefferies » 08:24
05/23/22
05/23
08:24
05/23/22
08:24
DDOG

Datadog

$94.83 /

-1.71 (-1.77%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$94.83 /

-1.71 (-1.77%)

DDOG Datadog
$94.83 /

-1.71 (-1.77%)

05/06/22 Truist
Datadog price target lowered to $170 from $200 at Truist
05/06/22 Morgan Stanley
Datadog price target lowered to $159 from $210 at Morgan Stanley
05/06/22 Mizuho
Datadog price target lowered to $175 from $225 at Mizuho
05/06/22 Citi
Datadog price target lowered to $195 from $220 at Citi
DDOG Datadog
$94.83 /

-1.71 (-1.77%)

DDOG Datadog
$94.83 /

-1.71 (-1.77%)

DDOG Datadog
$94.83 /

-1.71 (-1.77%)

Recommendations
Snowflake price target lowered to $150 from $230 at Jefferies » 08:24
05/23/22
05/23
08:24
05/23/22
08:24
SNOW

Snowflake

$141.51 /

-5.36 (-3.65%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

07:43 Today Cowen
Snowflake price target lowered to $280 from $390 at Cowen
06:20 Today UBS
Snowflake price target lowered to $180 from $260 at UBS
05/20/22 Barclays
Snowflake price target lowered to $218 from $313 at Barclays
05/18/22 Mizuho
Snowflake price target lowered to $225 from $370 at Mizuho
SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

SNOW Snowflake
$141.51 /

-5.36 (-3.65%)

Recommendations
Adobe price target lowered to $550 from $570 at Jefferies » 08:24
05/23/22
05/23
08:24
05/23/22
08:24
ADBE

Adobe

$399.67 /

+5.32 (+1.35%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$399.67 /

+5.32 (+1.35%)

ADBE Adobe
$399.67 /

+5.32 (+1.35%)

05/18/22 Wells Fargo
Adobe price target lowered to $525 from $600 at Wells Fargo
03/29/22 Exane BNP Paribas
Adobe initiated with an Outperform at Exane BNP Paribas
03/28/22 Argus
Adobe price target lowered to $575 from $764 at Argus
03/23/22 Jefferies
Adobe Creative Cloud price increases smaller than expected, says Jefferies
ADBE Adobe
$399.67 /

+5.32 (+1.35%)

ADBE Adobe
$399.67 /

+5.32 (+1.35%)

ADBE Adobe
$399.67 /

+5.32 (+1.35%)

ADBE Adobe
$399.67 /

+5.32 (+1.35%)

Recommendations
Atlassian price target lowered to $180 from $275 at Jefferies » 08:23
05/23/22
05/23
08:23
05/23/22
08:23
TEAM

Atlassian

$177.49 /

+2.81 (+1.61%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$177.49 /

+2.81 (+1.61%)

TEAM Atlassian
$177.49 /

+2.81 (+1.61%)

05/18/22 Wells Fargo
Atlassian price target lowered to $300 from $400 at Wells Fargo
05/16/22 Mizuho
Atlassian price target lowered to $360 from $500 at Mizuho
05/10/22 Truist
Atlassian price target lowered to $220 from $375 at Truist
04/29/22 Canaccord
Atlassian price target lowered to $300 from $375 at Canaccord
TEAM Atlassian
$177.49 /

+2.81 (+1.61%)

TEAM Atlassian
$177.49 /

+2.81 (+1.61%)

TEAM Atlassian
$177.49 /

+2.81 (+1.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.